Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Hotspots and trends of perianal fistula of Crohn's disease: A bibliometric analysis

Liang L., Li L., Wang D., Zhang X., Zhang X., Tian G.

Laboratory Study on Autoimmune Research, published in Medicine (Baltimore) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Medicine (Baltimore) (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40797408
PMCID
PMC12338274
DOI
10.1097/md.0000000000043854

Abstract (original English)

Background Perianal fistula is a frequent and severe complication of Crohn disease (CD). With the rising incidence of perianal fistulas in CD (pfCD), research activity in this field has grown substantially. Although several reviews have addressed CD and pfCD, comprehensive analyses summarizing research trends and hotspots in pfCD remain limited. Method Relevant articles and reviews were retrieved from the Web of Science Core Collection database. Citespace (version 6.3.1), Scimago Graphica (version 1.0.42), and VOSviewer (version 1.6.15) were used to systematically analyze data on publications, countries, institutions, authors, and keywords. Results Visual analysis of 692 articles on pfCD from 2004 to 2024 revealed evolving trends and research foci in the field. From 2004 to 2015, annual publication output remained relatively stable; however, it increased markedly thereafter, reaching 65 articles in 2024. Institutions from Europe and North America have contributed substantially to the field. Recent studies have focused on mesenchymal stem cells therapy, anti-tumor necrosis factor treatment, surgical interventions, diagnostic strategies, and therapeutic outcomes. Conclusion This bibliometric analysis provides a comprehensive overview of developmental trends and emerging hotspots in pfCD research, offering valuable insights for future investigations.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansRectal FistulaCrohn DiseaseBibliometrics

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research